Hot Pursuit     27-Nov-23
CRISIL revises AGS Transact's outlook to 'negative'; reaffirms 'A+' rating
AGS Transact Technologies (AGS) said that CRISIL Ratings has revised its outlook on the long-term bank facilities of the company to 'negative’ from 'stable’ while reaffirming the rating at 'CRISIL A+’.

The credit rating stated that the revision in outlook reflects only limited improvement in the debt protection metrics of AGS, compared to expectations, with debt levels continuing to be high due to slow recovery in receivables.

The rating continues to reflect healthy business risk profile of AGS, driven by its established market position in the ATM managed services industry, increasing presence in digital payment solutions and longstanding association with customer banks. The rating is also supported by adequate operating efficiency, which ensures steady cash generation.

These strengths are partially offset by average financial risk profile, large working capital requirement and risk of proliferation of digital payments in the long term, leading to stagnancy in demand for ATMs in the domestic market.

"Recovery in pending receivables will be critical to ensure sustained improvement in debt protection metrics and financial risk profile over the medium term, as cash accrual will only suffice to meet repayment obligations and a part of the capex; this will remain a key monitorable,” CRISIL said in a statement.

AGS Transact Technologies is one of India’s leading providers of end-to-end cash and digital payment solutions including customized solutions serving the banking, retail, petroleum and transit sectors. Operations covered approximately 2,200 cities and towns, servicing about 4,90,000 machines or customer touch points across India, as of 30 September 2023.

The company has reported a consolidated net loss of Rs 60.90 crore in the quarter ended September 2023 as against net profit of Rs 20.67 crore during the previous quarter ended September 2022. Sales declined 8.96% to Rs 376.54 crore in Q2 FY24 as compared with Q2 FY23.

The scrip had lost 0.86% to end at Rs 88.37 on the BSE on Friday.

Domestic equity markets are shut today on account of Guru Nanak Jayanti.

Previous News
  AGS Transact Technologies reports consolidated net loss of Rs 15.38 crore in the December 2023 quarter
 ( Results - Announcements 08-Feb-24   07:29 )
  AGS Transact Techs. to conduct board meeting
 ( Corporate News - 10-Dec-24   20:19 )
  Novus Technologies plans to raise funds
 ( Corporate News - 21-Dec-23   14:19 )
  AGS Transact completes deployment of 270 cash vans
 ( Hot Pursuit - 04-Dec-23   13:25 )
  AGS Transact Technologies to hold board meeting
 ( Corporate News - 03-Nov-22   18:43 )
  AGS Transact Technologies reports consolidated net profit of Rs 12.44 crore in the December 2022 quarter
 ( Results - Announcements 07-Feb-23   07:32 )
  AGS Transact Technologies consolidated net profit rises 2064.06% in the June 2024 quarter
 ( Results - Announcements 24-Jul-24   07:31 )
  Shares of AGS Transact Technologies get listed
 ( Corporate News - 31-Jan-22   09:08 )
  AGS Transact Technologies reports consolidated net loss of Rs 4.45 crore in the March 2024 quarter
 ( Results - Announcements 30-May-24   07:41 )
  AGS Transact Technologies reports consolidated net loss of Rs 60.90 crore in the September 2023 quarter
 ( Results - Announcements 04-Nov-23   07:37 )
  AGS Transact Tech makes muted debut
 ( Hot Pursuit - 31-Jan-22   10:18 )
Other Stories
  SMS Pharma’s Hyderabad facility completes USFDA inspection with 1 observation
  22-Mar-25   16:28
  Adani Enterprises arm incorporates wholly owned subsidiary in Dubai
  22-Mar-25   15:26
  Godrej Properties acquires 10 acres of land in Bengaluru for Rs 2,500 cr project
  22-Mar-25   14:28
  M&M to raise prices of SUV and CV range as input price pressures mount
  22-Mar-25   13:27
  ICRA reaffirms ratings of Data Patterns at 'A' with 'positive’ outlook
  22-Mar-25   12:26
  RIL's step-down subsidiary acquires 74% stake in Nauyaan Shipyard for Rs 383 crore
  22-Mar-25   11:33
  REC’s board to mull fund raising plan on 26th March
  22-Mar-25   11:12
  L&T elevates Subramanian Sarma as deputy MD
  22-Mar-25   10:12
  Ola Electric denies sales slump, blames vendor dispute for registration backlog
  22-Mar-25   09:10
  Alembic Pharma’s Gujarat facility clears USFDA inspection
  22-Mar-25   09:03
Back Top